BCR and posterior cortical atrophy: Notably, of the patients with BCR, rs735396 (TC+CC) and rs2464196 (GA+AA) carriers demonstrated significantly higher risks of tumors developing higher Gleason grades (3, 4, or 5) compared with the overall PCa population [OR = 2.628 (95% CI = 1.377-5.017, p = 0.003) and OR = 2.401 (95% CI = 1.268-4.547, p = 0.006), respectively; Tables 5 and 6].